| Literature DB >> 31469328 |
Kenneth M Heidel1, Cynthia S Dowd1.
Abstract
Phosphonates, often used as isosteric replacements for phosphates, can provide important interactions with an enzyme. Due to their high charge at physiological pH, however, permeation into cells can be a challenge. Protecting phosphonates as prodrugs has shown promise in drug delivery. Thus, a variety of structures and cleavage/activation mechanisms exist, enabling release of the active compound. This review describes the structural diversity of these pro-moieties, relevant cleavage mechanisms and recent advances in the design of phosphonate prodrugs.Entities:
Keywords: drug discovery; medicinal chemistry; phosphonate; prodrug activation; prodrugs
Mesh:
Substances:
Year: 2019 PMID: 31469328 PMCID: PMC6722485 DOI: 10.4155/fmc-2018-0591
Source DB: PubMed Journal: Future Med Chem ISSN: 1756-8919 Impact factor: 3.808